Skip to main content

Lexeo Therapeutics, Inc. Common Stock (LXEO) Stock

Lexeo Therapeutics, Inc. Common Stock Stock Details, Movements and Public Alerts

Stock Details

Lexeo Therapeutics, Inc. Common Stock (LXEO), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $6.66. Over the past 52 weeks, it has ranged between $1.45 and $10.99. This places the current price at 60.6% of its 52-week high and 359.3% above its 52-week low. Recent trading volume was recorded at 1,613,737. The 14-day Relative Strength Index (RSI) stands at 51.44, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $7.67 by 13.17%. Similarly, it is below its 200-day moving average of $6.66 by 0.00%. The MACD histogram is 0.13, indicating bullish momentum (MACD Line: -0.09, Signal Line: -0.22).

52-Week Range

$10.99 - $1.45

-39.40% from high · +359.31% from low

Avg Daily Volume

750,673

20-day average

100-day avg: 1,217,389

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

4.02

EV/EBITDA

-6.02

EPS (TTM)

-$2.50

Beta

1.80

More volatile than market

Q:How is LXEO valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is LXEO's risk profile compared to the market?
With a beta of 1.80, Lexeo Therapeutics, Inc. Common Stock is significantly more volatile than the market. For every 10% market move, this stock tends to move 18% in the same direction. Higher beta stocks offer greater potential returns but with increased risk. The price-to-book ratio of 4.02 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

EBITDA

$-112,933,000

Return on Equity

-80.70%

Return on Assets

-44.70%

Revenue Growth (YoY)

0.00%

Earnings Growth (YoY)

0.00%

Q:How profitable and efficient is LXEO's business model?
Profitability metrics are not available for this stock.
Q:What are LXEO's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$486.1M

Revenue (TTM)

$0

Revenue/Share (TTM)

$0.00

Shares Outstanding

72.99M

Book Value/Share

$2.20

Asset Type

Common Stock

Q:What is LXEO's market capitalization and position?
Lexeo Therapeutics, Inc. Common Stock has a market capitalization of $486.1M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 72.99M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
Q:How does LXEO's price compare to its book value?
Lexeo Therapeutics, Inc. Common Stock's book value per share is $2.20, while the current stock price is $6.66, resulting in a price-to-book (P/B) ratio of 3.03. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$19.64

194.89% upside potential

Analyst Recommendations

Strong Buy

2

Buy

9

Hold

0

Sell

0

Strong Sell

0

Q:How reliable are analyst predictions for LXEO?
11 analysts cover LXEO with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $19.64 implies 194.9% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on LXEO?
Current analyst recommendations:2 Strong Buy, 9 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Mar 15, 2026, 02:23 AM

Technical Indicators

RSI (14-day)

51.44

Neutral

50-Day Moving Average

$7.67

-13.17% below MA-50

200-Day Moving Average

$6.66

0.00% below MA-200

MACD Line

-0.09

MACD Signal

-0.22

MACD Histogram

0.13

Bullish

Q:What does LXEO's RSI value tell investors?
The RSI (Relative Strength Index) for LXEO is currently 51.44, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being below the 50-day moving average, this shows mixed signals requiring careful analysis.
Q:How should traders interpret LXEO's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.09 above the signal line at -0.22, with histogram at 0.13. This bullish crossover suggests upward momentum is building. The 50-day MA ($7.67) is above the 200-day MA ($6.66), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently between the MAs, suggesting transition.

Indicators last updated: Mar 11, 2026, 12:49 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for LXEO and get notified when the price changes.

Stay Ahead of the Market with Lexeo Therapeutics, Inc. Common Stock Alerts

Set up price alerts for Lexeo Therapeutics, Inc. Common Stock and get notified instantly when the price hits your target. Never miss an important price movement again.